NIDA to hold press conference on prescription drug misuse, abuse, and addiction

News conference and research update, Tuesday, April 10, 2001

WHAT:
A press conference, followed by a research update, to raise awareness about recent trends in the misuse and abuse of prescription drugs in the United States.

WHO:
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, and several partners, including: AARP, American Academy of Family Physicians, American Pharmaceutical Association, National Association of Chain Drug Stores, National Community Pharmacists Association, National Council on Patient Information and Education , and Pharmaceutical Research and Manufacturers of America (PhRMA).

WHEN:
Tuesday, April 10, 2001
10 am: Press Conference
1 pm: Research Update

WHERE:
National Press Club � Holeman Lounge
529 14th St. NW, 13th Floor
Washington, DC

WHY:
An estimated 4 million people 12 years or older used controlled sedatives, stimulants, or opiates for non-medical reasons in 1999, with almost half of them reporting that they used prescription drugs non-medically for the first time in the previous year. NIDA�s initiative will seek to increase awareness of this disturbing trend in the misuse and abuse of prescription drugs and to promote additional research on this topic.

WEBCAST:
Both the Press Conference and Research Update will be available via a webcast at www.drugabuse.gov starting at 10 a.m.

Media are invited to attend. For more information and to register, call the NIDA Press Office, 301-443-6245.

The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports more than 85 percent of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on the health effects of drugs of abuse and other topics can be ordered free of charge in English and Spanish through NIDA Infofax at 1-888-NIH-NIDA (644-6432) or 1-888-TTY-NIDA (889-6432) for the deaf. These fact sheets and further information on NIDA research and other activities can be found on the NIDA home page at http://www.drugabuse.gov.

Agenda: Prescription Drugs: Misuse, Abuse, and Addiction: A Research Update

1:00 p.m. � 1:15 p.m.
Welcome
Alan I. Leshner, Ph.D.
Director, National Institute on Drug Abuse

1:15 p.m. � 1:35 p.m.
Biological Bases of Drug Tolerance and Dependence
Alice Young, Ph.D.
Professor of Psychology, Psychiatry, and Behavioral Neurosciences
Wayne State University

1:35 p.m. � 1:55 p.m.
An Epidemiologic Overview of Prescription Drug Misuse
Howard Chilcoat, Sc.D.
Associate Professor, Department of Mental Hygiene
Johns Hopkins University

1:55 p.m. � 2:15 p.m.
Prescription Drug Use and Misuse in the Elderly
Kenneth Schmader, M.D.
Associate Professor of Medicine-Geriatrics
Duke University Medical Center

2:15 p.m. � 2:30 p.m.
First-Half Wrap-up and Discussion

2:30 p.m. � 2:45 p.m.
Break

2:45 p.m. � 3:05 p.m.
Pharmacotherapy of ADHD and Later Substance Abuse
Timothy E. Wilens, M.D.
Director, Substance Abuse Services
Pediatric Psychopharmacology Unit
Massachusetts General Hospital
Associate Professor of Psychiatry
Harvard University

3:05 p.m. � 3:25 p.m.
Physicians� Decisions To Prescribe Potentially Addictive Medications
Richard L. Brown, M.D., M.P.H.
Associate Professor, Department of Family Medicine
University of Wisconsin Medical School

3:25 p.m. � 3:45 p.m.
Substance Abuse Issues in Chronic Pain Management
Steven Passik, Ph.D.
Director of Oncology Symptom Control Research
Community Cancer Care, Inc., Indianapolis, IN

3:45 p.m. � 4:30 p.m.
Wrap-up and Final Discussion

SPEAKERS:

Richard L. Brown, M.D., M.P.H.
Associate Professor
Department of Family Medicine
University of Wisconsin Medical School 777 South Mills Street
Madison, WI 53715
(608) 262-6349
(608) 263-5813 FAX
rlbrown@fammed.wisc.edu

Alice Young, Ph.D.
Professor of Psychology, Psychiatry, and Behavioral Neurosciences
Department of Psychology
Wayne State University
71 West Warren Avenue
Detroit, MI 48202
(313) 577-3290
(313) 577-1377 FAX
ad4579@wayne.edu

Howard Chilcoat, Sc.D.
Associate Professor
Department of Mental Hygiene
School of Hygiene and Public Health
Johns Hopkins University
624 North Broadway
Baltimore, MD 21205
(410) 955-3908
(410) 955-9088 FAX
hchilcoa@jhsph.edu

Steven D. Passik, Ph.D.
Director
Oncology Symptom Control Research
Community Cancer Care, Inc.
115 West 19th Street
Indianapolis, IN 46202
(317) 833-1225
sdpccc@aol.com

Kenneth Schmader, M.D.
Associate Professor of Medicine-Geriatrics
Duke University Medical Center
GRECC (182)
VA Medical Center
508 Fulton Street
Durham, NC 27705
(919) 286-6932
(919) 286-6823 FAX

Timothy E. Wilens, M.D.
Director
Substance Abuse Services
Pediatric Psychopharmacology Unit
Massachusetts General Hospital
Associate Professor of Psychiatry
Harvard Medical School
ACC 725
15 Parkman Street
Boston, MA 02114-2696
(617) 726-1731
(617) 724-1540 FAX
wilens@helix.mgh.harvard.edu